Aurinia tells patients with lupus it's okay to 'get uncomfortable'
The campaign compares the discomfort of testing to the consequences of unchecked kidney health.
Stay updated with breaking news from Max Colao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The campaign compares the discomfort of testing to the consequences of unchecked kidney health.
Volker Knappertz, MD, as Executive Vice President, Research and Development, to lead the consolidated R&D function and to further enhance and advance the Aurinia pipelineScott Habig, as Chief Commercial Officer, to lead and enhance Aurinia’s commercial capabilities, replacing Max Colao, who led the formation of the...
14.07.2022 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced the appointment of three seasoned leaders to the ... Seite 1
Aurinia Pharmaceuticals Inc. (NASDAQ:NASDAQ:AUPH) Q1 2022 Earnings Conference Call May 10, 2022, 08:30 AM ET Company Participants Dana Lynch - Director of Corporate Communications &...
AUPH earnings call for the period ending September 30, 2021.